Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry

Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session

Benzinga Real-time News ·  {{timeTz}}

Gainers

  • Helius Medical Technologies, Inc. (NASDAQ:HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.
  • Kaspien Holdings Inc. (NASDAQ:KSPN) gained 112.4% to $5.48.
  • Eargo, Inc. (NASDAQ:EAR) shares climbed 102.8% to $1.42. The company is scheduled to report Q2 earnings on Monday, August 8.
  • Poseida Therapeutics, Inc. (NASDAQ:PSTX) shares jumped 99.6% to $4.85 as the company entered into a strategic collaboration and license agreement with Roche Holdings AG, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies.
  • Applied DNA Sciences, Inc. (NASDAQ:APDN) climbed 75.7% to $4.92 on continued strength after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus.
  • Kintara Therapeutics, Inc. (NASDAQ:KTRA) gained 70% to $0.3013 after the company entered into an equity purchase agreement with Lincoln Park Capital for up to $20 million.
  • Ping Identity Holding Corp. (NYSE:PING) shares climbed 59.8% to $27.92 after the company announced it will be acquired by Thoma Bravo for $28.50 per share in cash. Ping Identity also posted a Q2 loss of $0.34 per share.
  • Otonomy, Inc. (NASDAQ:OTIC) jumped 56% to $0.3887. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
  • Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) jumped 48% to $210.17 after the company announced the results from its APOLLO-B Phase 3 study of patisiran met the primary endpoint and also met the first secondary endpoint.
  • Chembio Diagnostics, Inc. (NASDAQ:CEMI) shares gained 48% to $1.08. Chembio Diagnostics is expected to release financial results for the second quarter after the close of trading on Thursday, August 4, 2022.
  • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) gained 40% to $1.6850 after the company announced a $3.5 million accelerated milestone payment from Zimmer Biomet. The amendment will also provide Zimmer with 350,000 warrants with an exercise price of $3.00 per share.
  • Endo International plc (NASDAQ:ENDP) gained 38% to $0.8099.
  • Tupperware Brands Corporation (NYSE:TUP) jumped 37% to $9.90 after the company reported better-than-expected Q2 results.
  • Tuniu Corporation (NASDAQ:TOUR) shares rose 25.2% to $1.0094 after dropping over 9% on Tuesday.
  • Rubius Therapeutics, Inc. (NASDAQ:RUBY) jumped 24% to $0.85.
  • ECMOHO Limited (NASDAQ:MOHO) gained 23.7% to $0.2054.
  • Clearwater Paper Corporation (NYSE:CLW) rose 22.3% to $42.56 following strong quarterly sales.
  • Donnelley Financial Solutions, Inc. (NASDAQ:DFIN) jumped 22.2% to $41.06 after the company reported better-than-expected Q2 results.
  • SoFi Technologies, Inc. (NASDAQ:SOFI) rose 22.1% to $7.84 after the company reported better-than-expected Q2 results and raised FY22 guidance.
  • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) jumped 20.2% to $23.43. Arcutis Biotherapeutics priced its 7.5 million share public offering of common stock at $20 per share.
  • Q&K International Group Limited (NASDAQ:QK) gained 20.2% to $2.26.
  • NeuroMetrix, Inc. (NASDAQ:NURO) climbed 20.2% to $4.3350. NeuroMetrix recently posted a Q2 loss of $0.17 per share.
  • MediaCo Holding Inc. (NASDAQ:MDIA) rose 19.8% to $4.54 after climbing around 14% on Tuesday. Standard General recently purchased roughly 12.9 million shares, bringing ownership to 92.4%.
  • Community Health Systems, Inc. (NYSE:CYH) gained 19.8% to $3.42. Community Health Systems Executive Chairman Wayne T Smith acquired a total of 1,000,000 shares at an average price of $2.95.
  • Alteryx, Inc. (NYSE:AYX) rose 19.3% to $60.35 following strong Q2 results.
  • Passage Bio, Inc. (NASDAQ:PASG) gained 19.1% to $2.2038. Passage Bio is expected to report Q2 financial results on August 4, 2022.
  • Semler Scientific, Inc. (NASDAQ:SMLR) rose 18.6% to $39.41 after the company reported Q2 earnings results.
  • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) gained 18.6% to $1.40.
  • MeiraGTx Holdings plc (NASDAQ:MGTX) rose 18.2% to $9.23 as the company reported financing agreement with Perceptive Advisors for up to $100 million secured by manufacturing facilities.
  • Moderna, Inc. (NASDAQ:MRNA) gained 16.4% to $187.27 after the company reported better-than-expected Q2 EPS and sales results and announced a $3 billion buyback.
  • Akso Health Group (NASDAQ:AHG) rose 16.4% to $1.1004.
  • Camping World Holdings, Inc. (NYSE:CWH) jumped 15.5% to $30.64 after the company reported better-than-expected Q2 EPS and sales results.
  • Generation Bio Co. (NASDAQ:GBIO) gained 14.7% to $7.32.
  • Unum Group (NYSE:UNM) surged 14.7% to $35.99 after the company reported better-than-expected Q2 EPS and sales results.
  • Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) gained 13.9% to $42.36. Ionis Pharmaceuticals recently announced positive topline results of the Phase 2b clinical trial of fesomersen in patients with end-stage renal disease (ESRD) on hemodialysis.
  • Upstart Holdings, Inc. (NASDAQ:UPST) jumped 13.3% to $28.73.
  • SemiLEDs Corporation (NASDAQ:LEDS) rose 13.2% to $3.68.
  • Aspira Women's Health Inc. (NASDAQ:AWH) gained 12.7% to $0.9168.
  • Coinbase Global, Inc. (NASDAQ:COIN) rose 12.5% to $75.60.
  • Robinhood Markets, Inc. (NASDAQ:HOOD) jumped 12% to $10.34 after the company reported better-than-expected Q2 EPS results.
  • Precipio, Inc. (NASDAQ:PRPO) rose 11.3% to $1.6395 after surging around 25% on Tuesday.
  • Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW) gained 10.9% to $96.92 following a Monday Wall Street Journal report suggesting Apollo Global Management was in advanced talks to acquire the company. Additionally, Wolfe Research upgraded the stock from Underperform to Peer Perform
  • PayPal Holdings, Inc. (NASDAQ:PYPL) rose 10% to $98.62 after the company reported better-than-expected Q2 results and raised FY22 EPS guidance.
  • Herbalife Nutrition Ltd. (NYSE:HLF) gained 9.9% to $26.61 following Q2 results.
  • Block, Inc. (NYSE:SQ) rose 7.8% to $85.25.


Losers

  • MMTec, Inc. (NASDAQ:MTC) dropped 50.8% to $3.8599 after jumping over 390% on Tuesday. MMTEC recently regained compliance with NASDAQ minimum bid price requirement.
  • AMTD Digital Inc. (NYSE:HKD) fell 35% to $1,092.03.
  • MDJM Ltd (NASDAQ:MDJH) shares dipped 34.6% to $2.23 after surging 90% on Tuesday.
  • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) fell 32.3% to $4.7872 after gaining around 39% on Tuesday. Meihua International Medical Technologies recently reported FY21 sales were up year over year.
  • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) dipped 31% to $39.50 after climbing around 23% on Tuesday.
  • Alpha Capital Acquisition Company (NASDAQ:ASPC) fell 31% to $7.00. Alpha Capital Acquisition Company’s shareholders approved proposed merger transaction with Semantix.
  • Mobile Global Esports Inc. (NASDAQ:MGAM) shares fell 26% to $6.39 after dropping around 33% on Tuesday.
  • Infinera Corporation (NASDAQ:INFN) dropped 22.5% to $5.03. The company recently posted upbeat quarterly results.
  • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 22.4% to $2.64 after jumping 63% on Tuesday.
  • Boqii Holding Limited (NYSE:BQ) dipped 21.9% to $2.1001.
  • Rocky Brands, Inc. (NASDAQ:RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.
  • Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) dropped 21.3% to $64.57 after the company reported worse-than-expected Q2 EPS and sales results and lowered FY22 sales guidance below estimates.
  • MAIA Biotechnology, Inc. (NASDAQ:MAIA) fell 20.3% to $5.17 after dipping around 17% on Tuesday. Maia Biotechnology received FDA Orphan Drug Designation for THIO for the treatment of small-cell lung cancer.
  • Nano Labs Ltd (NASDAQ:NA) dipped 20.1% to $7.35 amid post- IPO volatility after the stock opened for trade last month.
  • Knowles Corporation (NYSE:KN) fell 19% to $15.45 after reporting downbeat quarterly sales. Roth Capital downgraded Knowles from Buy to Neutral and lowered the price target from $30 to $17.
  • SolarEdge Technologies, Inc. (NASDAQ:SEDG) fell 19% to $295.82 after the company reported worse-than-expected Q2 EPS.
  • Orion Energy Systems, Inc. (NASDAQ:OESX) dropped 18.2% to $1.8892 after the company reported worse-than-expected Q1 EPS and sales results.
  • Match Group, Inc. (NASDAQ:MTCH) fell 17.1% to $63.56 after the company reported worse-than-expected Q2 sales and guided for muted top-line growth in the second half of 2022.
  • Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) shares fell 16.9% to $2.7188 after the company issued weak sales forecast for the second quarter. JP Morgan downgraded Hydrofarm from Overweight to Neutral.
  • Zovio Inc (NASDAQ:ZVO) fell 15.6% to $0.4810.
  • Viemed Healthcare, Inc. (NASDAQ:VMD) dropped 15.5% to $6.73 following Q2 results.
  • Leju Holdings Limited (NYSE:LEJU) fell 15.5% to $1.9671.
  • Triumph Group, Inc. (NYSE:TGI) dropped 14% to $14.26 after the company issued weak earnings forecast for FY23.
  • Southwest Gas Holdings, Inc. (NYSE:SWX) fell 13.3% to $75.75. Southwest Gas board concluded its strategic review.
  • Mercury Systems, Inc. (NASDAQ:MRCY) dropped 13.1% to $49.94 after the company reported worse-than-expected Q4 EPS and sales results. The company also issued Q1 EPS and sales guidance below analyst estimates.
  • Molecular Data Inc. (NASDAQ:MKD) fell 11.3% to $0.5774 following Q2 results.
  • Big 5 Sporting Goods Corporation (NASDAQ:BGFV) fell 9.9% to $11.58 after reporting weak Q2 results.
  • Owens & Minor, Inc. (NYSE:OMI) fell 9.6% to $33.12 after reporting downbeat quarterly sales. Owens & Minor expects sales of $9.8 billion - $10.1 billion (prior view $9.9 billion - $10.3 billion) versus the consensus of $10.15 billion.
  • Assurant, Inc. (NYSE:AIZ) dipped 9.3% to $155.63 following downbeat quarterly earnings.
  • Advanced Micro Devices, Inc (NASDAQ:AMD) fell 3.5% to $95.83. Advanced Micro Devices reported upbeat earnings for its second quarter and issued Q3 sales guidance with a midpoint below estimates.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal.


Moomoo is a financial information and trading app offered by Moomoo Techonologies Inc.


In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).


In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. ("Moomoo Financial SG") regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial SG is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.


In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.